Forbes quoted Mireille Jacobson of the USC Leonard Davis School on how pharmaceutical insurance coverage decisions are made based on drug efficacy.
Home » Some Say A Nonprofit Research Group Unfairly Influences Drug Prices (Forbes)
Related Posts
In the News
October 2, 2023
Jimmy Carter turns 99: 4 longevity lessons from the former president’s long life (NBC)
In the News
October 2, 2023
In Sen. Feinstein’s death, lessons for all of us about when to leave work behind (Los Angeles Times)
In the News
September 27, 2023
